Cancer Council Victoria

Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study (2016) Ong JS, Cuellar-Partida G, Lu Y, Fasching PA, Hein A, Burghaus S, Beckmann M, et al. Journal article No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing (2016) Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, et al. Journal article Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs) (2016) Darabi H, Beesley J, Droit A, Kar S, Nord S, Marjaneh MM, Soucy P, et al. Journal article Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent (2016) Guo Y, Andersen SW, Shu XO, Michailidou K, Bolla MK, Wang Q, Garcia-Closas M, et al. Journal article Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation (2016) Ghoussaini M, French JD, Michailidou K, Nord S, Beesley J, Canisus S, Hillman KM, et al. Journal article Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer (2016) Shi J, Zhang Y, Zheng W, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, et al. Journal article Genetic predisposition to ductal carcinoma in situ of the breast (2016) Petridis C, Brook MN, Shah V, Kohut K, Gorman P, Caneppele M, Levi D, et al. Journal article Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry (2016) Zhao Z, Wen W, Michailidou K, Bolla MK, Wang Q, Zhang B, Long J, et al. Journal article Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study (2016) Dixon SC, Nagle CM, Thrift AP, Pharoah PDP, Pearce CL, Zheng W, Painter JN, et al. Journal article Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer (2016) Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Doerk T, Hillemanns P, et al. Journal article